Related Experiment Video
Updated: Jul 7, 2026

Quantification of Proteins Using Peptide Immunoaffinity Enrichment Coupled with Mass Spectrometry
Published on: July 31, 2011
1st NCI annual meeting on Clinical Proteomic Technologies for Cancer
1Pressure BioSciences, Inc., R&D, 321 Manley St, W. Bridgewater, MA 02379, USA. ftao@pressurebiosciences.com
Abstract:
The National Cancer Institute of the US National Institutes of Health established a Clinical Proteomic Technologies Initiative for Cancer (CPTI) in 2006. The first annual meeting organized by the CPTI program provided up-to-date information on the research activities and achievements at its first anniversary of this program. Presentations were made by leaders from the five centers nationwide of the Clinical Proteomic Technology Assessment for Cancer (CPTAC), and other principal investigators funded by the CPTI.

